EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The miR-320a/PRDX3 Axis Alleviates the Oxidative Stress and Fibrotic Alterations in Fibroblasts in Thyroid Eye Disease

Shenghua Liu, Jinping Yi, Shiyao Lu, Jiamin Cao, Bingyu Xie, Yao Tan, Wei Xiong

Investigative Ophthalmology & Visual Science · 14.07.2025 · 66 (9) · 41

DOI: 10.1167/iovs.66.9.41 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 14.07.2025. Verfasst von Shenghua Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Third Xiangya Hospital, Central South University, Yuelu District, Changsha, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, Oxidative Stress, Graves Ophthalmopathy, Fibroblasts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Thyroid eye disease (TED) is an autoimmune condition of the orbit characterized by significant morbidity. MicroRNAs (miRNAs) have been identified as key modulators of immune responses and fibrotic processes, with miR-320a emerging as a potential modulator in TED pathogenesis.

Methods

This study investigated miR-320a's role in TED by analyzing its expression in TED tissues and assessing the impact of its inhibition on fibroblast activation, fibrosis, and oxidative stress. Peroxiredoxin 3 (PRDX3) was identified as a direct target of miR-320a, and its functional consequences were evaluated. In vivo experiments were also conducted to validate the findings.

Results

Inhibition of miR-320a reduced fibroblast activation, fibrosis, and oxidative stress markers. PRDX3 knockdown amplified these effects, indicating its importance in miR-320a-mediated pathways. Overexpression of miR-320a further promoted fibroblast activation, as evidenced by decreased cell viability, DNA synthesis, and the expression levels of fibrotic markers. PRDX3 overexpression could also notably eliminate the effects of miR-320a overexpression. In vivo targeting of the miR-320a/PRDX3 axis reduced oxidative stress and fibrosis in TED models.

Conclusions

The study highlights the critical role of miR-320a in TED pathogenesis through its regulation of orbital fibroblast (OF) activation, fibrosis, oxidative stress, and the p38 mitogen-activated protein kinase (p38 MAPK) signaling pathway, mediated by its interaction with PRDX3. Targeting the miR-320a/PRDX3 axis represents a promising therapeutic strategy to alleviate the oxidative stress and fibrotic alterations in TED, underscoring the potential of miR-320a as a therapeutic target in managing TED progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOxidative StressGraves OphthalmopathyFibroblastsPeroxiredoxin IIIGene Expression RegulationHumansFibrosisAnimalsMiceCells, CulturedMaleDisease Models, AnimalBlotting, Western

Substanzen

MicroRNAsMIRN320 microRNA, humanPeroxiredoxin IIIPRDX3 protein, human

Autor:innen und Institutionen

  • Department of Ophthalmology, The Third Xiangya Hospital, Central South University, Yuelu District, Changsha, Hunan, People's Republic of China.

Zitieren

APA

Liu, S., Yi, J., Lu, S., Cao, J., Xie, B., Tan, Y., & Xiong, W. (2025). The miR-320a/PRDX3 Axis Alleviates the Oxidative Stress and Fibrotic Alterations in Fibroblasts in Thyroid Eye Disease. Investigative Ophthalmology & Visual Science, 66(9), 41. https://doi.org/10.1167/iovs.66.9.41

Vancouver

Liu S, Yi J, Lu S, Cao J, Xie B, Tan Y, et al. The miR-320a/PRDX3 Axis Alleviates the Oxidative Stress and Fibrotic Alterations in Fibroblasts in Thyroid Eye Disease. Investigative Ophthalmology & Visual Science. 2025;66(9):41. doi:10.1167/iovs.66.9.41

BibTeX
@article{Liu2025,
  author = {Liu, Shenghua and Yi, Jinping and Lu, Shiyao and Cao, Jiamin and Xie, Bingyu and Tan, Yao and Xiong, Wei},
  title = {The miR-320a/PRDX3 Axis Alleviates the Oxidative Stress and Fibrotic Alterations in Fibroblasts in Thyroid Eye Disease},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  volume = {66},
  number = {9},
  pages = {41},
  doi = {10.1167/iovs.66.9.41}
}
Kostenlos starten →